RhythmAnalytics vs Rapid RV/LV
AI Verdict
Choose RhythmAnalytics if…
Choose RhythmAnalytics if your primary need is automated, AI-powered interpretation of cardiac arrhythmias from single-lead ECG data to enhance clinical decision support. This tool is ideal for integrating with various FDA-cleared ECG devices, including wearables and Holter monitors, to provide continuous or intermittent rhythm analysis for a broad spectrum of cardiac conditions.
View RhythmAnalytics →Choose Rapid RV/LV if…
Choose Rapid RV/LV if you require rapid, AI-powered assessment of pulmonary embolism severity directly from CTPA scans. This tool is specifically designed to automatically measure right and left ventricle ratios, providing critical, objective data within minutes to aid in urgent patient triage and management in acute care settings.
View Rapid RV/LV →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | RhythmAnalytics | Rapid RV/LV |
|---|---|---|
| Pricing | Contact vendor | Contact vendor for pricing information. |
| Deployment | Cloud-based API | Unknown |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid RV/LVTool B, Rapid RV/LV, is integrated into the comprehensive RapidAI platform, which offers features like mobile alerts, in-app messaging, and EMR integration, streamlining clinical workflows for end-users. While Tool A, RhythmAnalytics, is a cloud-based API for integration, its primary usability is more for developers rather than direct clinical end-users.
Clinical Value
TieBoth tools offer significant clinical value, backed by FDA clearance and robust clinical evidence in their respective domains. Tool A provides highly accurate, automated interpretation of numerous cardiac arrhythmias from ECG data. Tool B offers rapid, standardized assessment of pulmonary embolism severity from CTPA scans, crucial for timely intervention in a life-threatening condition. Both address critical clinical needs with validated AI, making it difficult to distinguish one as having inherently more value without specific comparative outcome data.
Pricing & Value
Rapid RV/LVTool B, Rapid RV/LV, provides slightly more transparency regarding its pricing model, indicating a custom enterprise annual subscription that starts around $12,000 for a single module in the US and includes support and training. Tool A only states 'contact vendor' for pricing, offering less insight into its commercial approach.
Enterprise Readiness
Rapid RV/LVTool B explicitly states it has a Business Associate Agreement (BAA) and is deployed on the robust, hybrid Rapid Enterpriseu2122 Platform, designed for seamless integration across hospital systems with a focus on security, performance, and scalability. Tool A's BAA status is unspecified in the provided facts, and while cloud-based, its enterprise platform context is less detailed.
Innovation
TieBoth tools demonstrate high levels of innovation by leveraging advanced AI to address critical clinical challenges. Tool A uses enhanced deep learning for comprehensive arrhythmia detection from single-lead ECGs, particularly for remote monitoring. Tool B's rapid, automated PE severity assessment and its integration into a 'deep clinical AI' platform that includes advanced visualization and 'no-click' 3D reconstruction are also cutting-edge advancements.
Support & Docs
Rapid RV/LVTool B, as part of the RapidAI platform, clearly outlines its support and documentation offerings, including 24/7 live support, training sessions, and various educational resources. Tool A has no readily available information regarding its specific support and documentation in the provided facts or search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | RhythmAnalytics | Rapid RV/LV |
|---|---|---|
| Name | RhythmAnalytics | Rapid RV/LV |
| Company | Biofourmis Singapore Pte. | RapidAI (formerly iSchemaView) |
| Primary Application | AI-powered automated interpretation of cardiac arrhythmias from single-lead ECG data. | AI-powered rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. |
| Data Input | Single-lead ECG data (from FDA-cleared ECG devices: Holter, event recorders, wearable sensors) | CTPA scans |
| Key Output/Analysis | AI-based automated interpretation of cardiac arrhythmias, detection of over 15 types of cardiac arrhythmias, beat-by-beat morphology computation, QRS and Ventricular Ectopic Beat detection, QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis. | AI-powered analysis of CTPA images, automated measurement of right and left ventricle diameters, calculation of RV/LV ratio, annotated images showing ventricular measurements, rapid results. |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring RhythmAnalytics and Rapid RV/LV.